<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35233035</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study.</ArticleTitle><Pagination><StartPage>3369</StartPage><MedlinePgn>3369</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3369</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-07414-x</ELocationID><Abstract><AbstractText>Survivors to COVID-19 have described long-term symptoms after acute disease. These signs constitute a heterogeneous group named long COVID or persistent COVID. The aim of this study is to describe persisting symptoms 6 months after COVID-19 diagnosis in a prospective cohort in the Northwest Spain. This is a prospective cohort study performed in the COHVID-GS. This cohort includes patients in clinical follow-up in a health area of 569,534 inhabitants after SARS-CoV-2/COVID-19 diagnosis. Clinical and epidemiological characteristics were collected during the follow up. A total of 248 patients completed 6&#xa0;months follow-up, 176 (69.4%) required hospitalization and 29 (10.2%) of them needed critical care. At 6 months, 119 (48.0%) patients described one or more persisting symptoms. The most prevalent were: extra-thoracic symptoms (39.1%), chest symptoms (27%), dyspnoea (20.6%), and fatigue (16.1%). These symptoms were more common in hospitalized patients (52.3% vs. 38.2%) and in women (59.0% vs. 40.5%). The multivariate analysis identified COPD, women gender and tobacco consumption as risk factors for long COVID. Persisting symptoms are common after COVID-19 especially in hospitalized patients compared to outpatients (52.3% vs. 38.2%). Based on these findings, special attention and clinical follow-up after acute SARS-CoV-2 infection should be provided for hospitalized patients with previous lung diseases, tobacco consumption, and women.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>P&#xe9;rez-Gonz&#xe1;lez</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Group of Virology and Pathogenesis, Internal Medicine Department, &#xc1;lvaro Cunqueiro Hospital, Galicia Sur Health Research Institute (IIS Galicia Sur), Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo. St. Clara Campoamor N&#xba; 341, 36312, Vigo, Spain. alexandre.perez@iisgaliciasur.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Internal Medicine, Galicia Sur Health Research Institute (IIS Galicia Sur), Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain. alexandre.perez@iisgaliciasur.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ara&#xfa;jo-Ameijeiras</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Group of Virology and Pathogenesis, Internal Medicine Department, &#xc1;lvaro Cunqueiro Hospital, Galicia Sur Health Research Institute (IIS Galicia Sur), Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo. St. Clara Campoamor N&#xba; 341, 36312, Vigo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Internal Medicine, Galicia Sur Health Research Institute (IIS Galicia Sur), Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Villar</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pneumology Service, Galicia Sur Health Research Institute (IIS Galicia Sur), Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crespo</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Hospital Universitari de Bellvitge, IDIBEL, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poveda</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Group of Virology and Pathogenesis, Internal Medicine Department, &#xc1;lvaro Cunqueiro Hospital, Galicia Sur Health Research Institute (IIS Galicia Sur), Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo. St. Clara Campoamor N&#xba; 341, 36312, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Cohort COVID-19 of the Galicia Sur Health Research Institute</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CM20/00243</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>COV20/00698</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>COV20/00698</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Sci Rep. 2022 Aug 16;12(1):13873. doi: 10.1038/s41598-022-18023-z</RefSource><PMID Version="1">35974081</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Jorge Julio</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Del Campo</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Araujo</LastName><ForeName>Beatriz Gil</ForeName><Initials>BG</Initials></Investigator><Investigator ValidYN="Y"><LastName>G&#xf3;mez</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leiro</LastName><ForeName>Virginia</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Longueira</LastName><ForeName>Mar&#xed;a Rebeca</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xf3;pez-Dom&#xed;nguez</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ram&#xf3;n Lorenzo</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcos</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teresa P&#xe9;rez</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pati&#xf1;o</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>P&#xe9;rez</LastName><ForeName>Sonia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>P&#xe9;rez-Fern&#xe1;ndez</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramos</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Regueiro</LastName><ForeName>Benito</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Retresas</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivera</LastName><ForeName>Tania</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Souto</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taboada</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teijeira</LastName><ForeName>Susana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torres</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Val</LastName><ForeName>Vanesa</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vi&#xe9;itez</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35233035</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-07414-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berenguer J, Ryan P, Rodr&#xed;guez-Ba&#xf1;o J, et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin. Microbiol. Infect. 2020;26(11):1525&#x2013;1536. doi: 10.1016/j.cmi.2020.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.024</ArticleId><ArticleId IdType="pmc">PMC7399713</ArticleId><ArticleId IdType="pubmed">32758659</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jahdhami I, Al-Naamani K, Al-Mawali A. The post-acute COVID-19 syndrome (long COVID) Oman Med. J. 2021;36(1):e220&#x2013;e220. doi: 10.5001/omj.2021.91.</Citation><ArticleIdList><ArticleId IdType="doi">10.5001/omj.2021.91</ArticleId><ArticleId IdType="pmc">PMC7838343</ArticleId><ArticleId IdType="pubmed">33537155</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): An integrative classification. Int. J. Environ. Res. Pub. Health. 2021;18(5):2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S, O&#x2019;Connor R, Sivan M. Long COVID and chronic COVID syndromes. J. Med. Virol. 2021;93(3):1242&#x2013;1243. doi: 10.1002/jmv.26587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26587</ArticleId><ArticleId IdType="pmc">PMC7675759</ArticleId><ArticleId IdType="pubmed">33034893</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 2020;16(11):636&#x2013;644. doi: 10.1038/s41582-020-0398-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0398-3</ArticleId><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrandi PJ, Alway SE, Mohamed JS. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J. Appl. Physiol. 2020;129(4):864&#x2013;867. doi: 10.1152/japplphysiol.00321.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00321.2020</ArticleId><ArticleId IdType="pmc">PMC7832004</ArticleId><ArticleId IdType="pubmed">32673162</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgul E, Bener A, Atak M, et al. COVID-19 pandemic and psychological fatigue in Turkey. Int. J. Soc. Psychiatr. 2021;67(2):128&#x2013;135. doi: 10.1177/0020764020941889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0020764020941889</ArticleId><ArticleId IdType="pmc">PMC7355205</ArticleId><ArticleId IdType="pubmed">32650681</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021 doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv. 2021 doi: 10.1101/2020.12.24.20248802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27(1):89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: What is long-COVID and how should we manage it? Lung. 2021;199(2):113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Surda P, Whitehead E, Kumar BN. Early recovery following new onset anosmia during the COVID-19 pandemic: An observational cohort study. J. Otolaryngol.: Head Neck Surg. 2020;49(1):26. doi: 10.1186/s40463-020-00423-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40463-020-00423-8</ArticleId><ArticleId IdType="pmc">PMC7196882</ArticleId><ArticleId IdType="pubmed">32366299</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ascanio L, Pandolfini M, Cingolani C, et al. A. Olfactory dysfunction in COVID-19 patients prevalence and prognosis for recovering sense of smell. Otolaryngol. Head Neck Surg. 2021;164(1):82&#x2013;86. doi: 10.1177/0194599820943530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820943530</ArticleId><ArticleId IdType="pubmed">32662745</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, B&#xfc;ttiker P, Weissenberger S, Martin A, Ptacek R, Kream RM. Editorial: The pathogenesis of long-term neuropsychiatric COVID-19 and the role of microglia, mitochondria, and persistent neuroinflammation: A hypothesis. Med. Sci. Monit. 2021;10(27):e933015. doi: 10.12659/MSM.933015.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933015</ArticleId><ArticleId IdType="pmc">PMC8120907</ArticleId><ArticleId IdType="pubmed">34016942</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinna P, Grewal P, Hall JP, et al. Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline. J Neurol Sci. 2020;415:116969. doi: 10.1016/j.jns.2020.116969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116969</ArticleId><ArticleId IdType="pmc">PMC7832569</ArticleId><ArticleId IdType="pubmed">32570113</ArticleId></ArticleIdList></Reference><Reference><Citation>Karada&#x15f; &#xd6;, &#xd6;zt&#xfc;rk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci. 2020;41(8):1991&#x2013;1995. doi: 10.1007/s10072-020-04547-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04547-7</ArticleId><ArticleId IdType="pmc">PMC7316428</ArticleId><ArticleId IdType="pubmed">32588367</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez CM, D&#xed;az-Maroto I, Fern&#xe1;ndez-D&#xed;az E, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020;95(8):e1060&#x2013;e1070. doi: 10.1212/WNL.0000000000009937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009937</ArticleId><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL): A systematic review and meta-analysis. J. Med. Virol. 2021 doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, et al. Persistent poor health after covid-19 is not associated with respiratory complications or initial disease severity. Ann. Am. Thorac. Soc. 2021;18(6):997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E, Corsetti G, Romano C, et al. Serum metabolic profile in patients with long-covid (PASC) syndrome: Clinical implications. Front. Med. 2021;8(July):1&#x2013;8. doi: 10.3389/fmed.2021.714426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.714426</ArticleId><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>